Celiac Disease and the Microbiome
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Growing evidence supports the hypothesis that changes in both the composition and function of the intestinal microbiome are associated with a number of chronic inflammatory diseases including celiac disease (CD). One of the major advances in the field of microbiome studies over the last few decades has been the development of culture-independent approaches to identify and quantify the components of the human microbiota. The study of nucleic acids DNA and RNA found in feces or other biological samples bypasses the need for tissue cultures and also allows the characterization of non-cultivable microbes. Current evidence on the composition of the intestinal microbiome and its role as a causative trigger for CD is highly heterogeneous and sometimes contradictory. This review is aimed at summarizing both pre-clinical (basic science data) and clinical (cross-sectional and prospective studies) evidence addressing the relationship between the intestinal microbiome and CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to regulation of infection and commensal spread, microbiome-immune interactions are implicated in a variety of ‘non-communicable’ gastrointestinal diseases including inflammatory bowel disease (IBD)8 and celiac diseases,9 as well as extra-intestinal disorders ranging from rheumatic arthritis,10 metabolic syndrome,11 neurodegenerative disorder12 to malignancy.13”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815 · cited 1×
“At approximately three years of age, a child’s gut microbiota composition and diversity are very similar to the adult microbiota [30].”
BackgroundDominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774 · cited 1×
“In recent years, research into the early development of the microbiome has highlighted the influences of delivery mode, maternal/infant nutrition and antibiotics on the engraftment and subsequent changes in intestinal microbiome composition [33,34].”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“It is well acknowledged that the host can tightly control the microbiota, however, the microbiota also exerts a strong programming on host metabolism and immunity [73].”
BackgroundRinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462
Current understanding of the human microbiome
Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J. K., Lynch, S. V., & Knight, R. (2018) · Nature Medicine · doi:10.1038/nm.4517 · Cited by 2,609 · cited 1×
“More than 2 million genes are expressed by the human microbiome, and these genes encode for metabolic pathways that finally produce thousands of metabolites [21].”
BackgroundThe Placenta Harbors a Unique Microbiome
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008599 · Cited by 2,494 · cited 1×
“While it is generally assumed that microbiome engraftment occurs at birth during the passage through the vaginal canal, or via maternal skin microbiota in case of cesarean section, there are a few reports showing that a specific microbiota colonizes the placenta [31] and is detectable in the meconium [32], suggesting…”
BackgroundBifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387
Gut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778 · cited 1×
“Growing evidence supports the hypothesis that changes in gut microbiome composition and function are associated with a number of chronic inflammatory diseases including obesity [14], diabetes [15], inflammatory bowel disease [16] and cancer [17].”
BackgroundGlobal Prevalence of Celiac Disease: Systematic Review and Meta-analysis
Singh, P., Arora, A., Strand, T. A., Leffler, D. A., Catassi, C., Green, P. H., Kelly, C. P., Ahuja, V., & Makharia, G. K. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.037 · Cited by 1,743
Interactions between commensal intestinal bacteria and the immune system
Macpherson, A. J., & Harris, N. L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1373 · Cited by 1,610
Vaishnava, S., Yamamoto, M., Severson, K. M., Ruhn, K. A., Yu, X., Koren, O., Ley, R., Wakeland, E. K., & Hooper, L. V. (2011) · Science · doi:10.1126/science.1209791 · Cited by 1,412
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288 · cited 1×
“By competing for nutritional sources and producing anti-microbial molecules, beneficial gut bacteria counterbalance the growth of pathogenic bacteria and favor epithelial integrity [25,26].”
BackgroundGut Microbiome: Profound Implications for Diet and Disease
Hills, R., Pontefract, B., Mishcon, H., Black, C., Sutton, S., & Theberge, C. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,092
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Sun, M., Wu, W., Liu, Z., & Cong, Y. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1242-9 · Cited by 1,047 · cited 1×
“SCFA synthesized by commensal bacteria condition regulatory T-cells (Treg cells), specifically, one member of the SCFA, butyrate, helps T-cells to differentiate toward Treg cells [74].”
BackgroundJakobsson, H. E., Abrahamsson, T. R., Jenmalm, M. C., Harris, K., Quince, C., Jernberg, C., Björkstén, B., Engstrand, L., & Andersson, A. F. (2014) · Gut · doi:10.1136/gutjnl-2012-303249 · Cited by 1,011 · cited 1×
“Conversely, cesarean (C) section-born infants show less Bacteroidetes, and the diversity of this specific phylum is lower [37].”
BackgroundGut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months
Azad, M. B., Konya, T., Maughan, H., Guttman, D. S., Field, C. J., Chari, R. S., Sears, M. R., Becker, A. B., Scott, J. A., & Kozyrskyj, A. L. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121189 · Cited by 954 · cited 1×
“In recent years, research into the early development of the microbiome has highlighted the influences of delivery mode, maternal/infant nutrition and antibiotics on the engraftment and subsequent changes in intestinal microbiome composition [33,34].”
BackgroundIgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis
Peterson, D. A., McNulty, N. P., Guruge, J. L., & Gordon, J. I. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.013 · Cited by 828 · cited 2×
“were found in those who developed CD [68].”
BackgroundThe composition of the gut microbiota shapes the colon mucus barrier
Jakobsson, H. E., Rodríguez‐Piñeiro, A. M., Schütte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Bäckhed, F., Hansson, G. C., & Johansson, M. E. (2015) · The EMBO Reports · doi:10.15252/embr.201439263 · Cited by 700 · cited 1×
“This could possibly be explained by the fact that the intestinal mucus layer is more penetrable to bacteria and toxins where Proteobacteria prevail [96].”
BackgroundRutayisire, E., Huang, K., Liu, Y., & Tao, F. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0498-0 · Cited by 657 · cited 7×
“For example, vaginal delivery ensures the vertical mother–infant transmission for pivotal gut microbiome components such as Bacteroides and Bifidobacteria [36].”
BackgroundInfluentialGut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566 · cited 1×
“By competing for nutritional sources and producing anti-microbial molecules, beneficial gut bacteria counterbalance the growth of pathogenic bacteria and favor epithelial integrity [25,26].”
BackgroundFallani, M., Young, D., Scott, J., Norin, E., Amarri, S., Adam, R., Aguilera, M., Khanna, S., Gil, A., Edwards, C. A., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181d1b11e · Cited by 559 · cited 1×
“Some data also suggested that maternal antibiotic assumption during pregnancy shapes the gut microbiota in the offspring [44], albeit a cohort study found no statistically significant association between maternal use of antibiotics during pregnancy and CD risk in the offspring [45].”
BackgroundStene, L. C., Honeyman, M. C., Hoffenberg, E. J., Haas, J. E., Sokol, R. J., Emery, L., Taki, I., Norris, J. M., Erlich, H. A., Eisenbarth, G. S., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00741.x · Cited by 558 · cited 1×
“A longitudinal prospective cohort of genetically at-risk children demonstrated that an increased rate of rotavirus gastroenteritis may strengthen the risk of CD in infancy [57].”
BackgroundOtte, J.-M., Cario, E., & Podolsky, D. K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.007 · Cited by 505 · cited 1×
“This phenomenon has been named “lipopolysaccharide tolerance” [72].”
BackgroundIntroduction of Gluten, HLA Status, and the Risk of Celiac Disease in Children
Lionetti, E., Castellaneta, S., Francavilla, R., Pulvirenti, A., Tonutti, E., Amarri, S., Barbato, M., Barbera, C., Barera, G., Bellantoni, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400697 · Cited by 482 · cited 2×
“This phenomenon was initially hypothesized to be secondary to the timing of gluten introduction at weaning [10], although two large, randomized, and prospective high-risk, birth cohort-controlled trials have disputed this premise by demonstrating that neither delayed nor early gluten introduction modified the risk of…”
BackgroundResultSelf-citationRandomized Feeding Intervention in Infants at High Risk for Celiac Disease
Vriezinga, S. L., Auricchio, R., Bravi, E., Castillejo, G., Chmielewska, A., Crespo Escobar, P., Kolaček, S., Koletzko, S., Korponay-Szabo, I. R., Mummert, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404172 · Cited by 474 · cited 1×
“This phenomenon was initially hypothesized to be secondary to the timing of gluten introduction at weaning [10], although two large, randomized, and prospective high-risk, birth cohort-controlled trials have disputed this premise by demonstrating that neither delayed nor early gluten introduction modified the risk of…”
ResultThe Human Microbiome and Obesity: Moving beyond Associations
Maruvada, P., Leone, V., Kaplan, L. M., & Chang, E. B. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.005 · Cited by 471 · cited 1×
“Growing evidence supports the hypothesis that changes in gut microbiome composition and function are associated with a number of chronic inflammatory diseases including obesity [14], diabetes [15], inflammatory bowel disease [16] and cancer [17].”
BackgroundThe first large population based twin study of coeliac disease
Greco, L., Romino, R., Coto, I., Di Cosmo, N., Percopo, S., Maglio, M., Paparo, F., Gasperi, V, Limongelli, M. G., Cotichini, R., et al. (2002) · Gut · doi:10.1136/gut.50.5.624 · Cited by 465 · cited 1×
“the old paradigm is the lack of 100% CD concordance among monozygotic twins [12].”
BackgroundDICKE, W. K., WEIJERS, H. A., & KAMER, J. H. V. D. (1953) · Acta Paediatrica · doi:10.1111/j.1651-2227.1953.tb05563.x · Cited by 459 · cited 1×
“Although the recognition of the causal link between gluten and celiac disease (CD) was unveiled in the 1950s [1], what factor (or factors) triggers the loss of immune tolerance to gluten in genetically predisposed subjects still remains unknown.”
BackgroundBouziat, R., Hinterleitner, R., Brown, J. J., Stencel-Baerenwald, J. E., Ikizler, M., Mayassi, T., Meisel, M., Kim, S. M., Discepolo, V., Pruijssers, A. J., et al. (2017) · Science · doi:10.1126/science.aah5298 · Cited by 448 · cited 1×
“Another study that looked at the effect of viral triggers and Th1 response recognized reovirus as a possible cofactor for both inappropriate immune activation and subsequent loss of tolerance to gliadin [54].”
BackgroundPhysiology of Consumption of Human Milk Oligosaccharides by Infant Gut-associated Bifidobacteria
Asakuma, S., Hatakeyama, E., Urashima, T., Yoshida, E., Katayama, T., Yamamoto, K., Kumagai, H., Ashida, H., Hirose, J., & Kitaoka, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248138 · Cited by 442 · cited 1×
“The human milk oligosaccharides (HMOs) select the growth of commensals such as Bifidobacteria and prevent the growth of potential pathogens such as Clostridium difficile [41,42].”
BackgroundZyrek, A. A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., & Schmidt, M. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00836.x · Cited by 428 · cited 1×
“coli strain Nissen 1917 on gut barrier function has been reported [87].”
BackgroundImbalance in the composition of the duodenal microbiota of children with coeliac disease
Nadal, I., Donant, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47410-0 · Cited by 396
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974
Catassi, C., Kryszak, D., Bhatti, B., Sturgeon, C., Helzlsouer, K., Clipp, S. L., Gelfond, D., Puppa, E., Sferruzza, A., & Fasano, A. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.514285 · Cited by 366
Self-citationThe role of diet on gut microbiota composition.
Bibbò, S., Ianiro, G., Giorgio, V., Scaldaferri, F., Masucci, L., Gasbarrini, A., & Cammarota, G. (2016) · PubMed · Cited by 358
Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease
Collado, M. C., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.061366 · Cited by 354
De Palma, G., Nadal, I., Medina, M., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-63 · Cited by 330
Olivares, M., Neef, A., Castillejo, G., Palma, G. D., Varea, V, Capilla, A., Palau, F., Nova, E., Marcos, A., Polanco, I., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-306931 · Cited by 296
Cesarean Delivery Is Associated With Celiac Disease but Not Inflammatory Bowel Disease in Children
Decker, E., Engelmann, G., Findeisen, A., Gerner, P., Laaβ, M., Ney, D., Posovszky, C., Hoy, L., & Hornef, M. W. (2010) · Pediatrics · doi:10.1542/peds.2009-2260 · Cited by 277 · cited 1×
“However, while it is uncertain if these changes might explain some reports of an increased risk of CD for children born via C-section [38,39], it should be acknowledged that the association between C-section and CD is still controversial [40].”
BackgroundA distinctive 'microbial signature' in celiac pediatric patients
Schippa, S., Iebba, V., Barbato, M., Di Nardo, G., Totino, V., Checchi, M., Longhi, C., Maiella, G., Cucchiara, S., & Conte, M. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-175 · Cited by 256
Self-citationSellitto, M., Bai, G., Serena, G., Fricke, W. F., Sturgeon, C., Gajer, P., White, J. R., Koenig, S. S. K., Sakamoto, J., Boothe, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033387 · Cited by 251
Self-citationCaminero, A., Galipeau, H. J., McCarville, J. L., Johnston, C. W., Bernier, S. P., Russell, A. K., Jury, J., Herran, A. R., Casqueiro, J., Tye-Din, J. A., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.041 · Cited by 250 · cited 1×
“To this extent, it is of note that, after the bacterial proteolytic degradation of gliadin, peptides could still be toxic and eventually cross the intestinal barrier more easily [98].”
BackgroundEvidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.
Kagnoff, M. F., Paterson, Y. J., Kumar, P. J., Kasarda, D. D., Carbone, F. R., Unsworth, D. J., & Austin, R. K. (1987) · Gut · doi:10.1136/gut.28.8.995 · Cited by 227 · cited 1×
“Patients with CD display higher antibody titers against human adenovirus serotype 2 [55,56].”
BackgroundPregnancy Outcome and Risk of Celiac Disease in Offspring: A Nationwide Case-Control Study
Mårild, K., Stephansson, O., Montgomery, S., Murray, J. A., & Ludvigsson, J. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.047 · Cited by 218 · cited 1×
“However, while it is uncertain if these changes might explain some reports of an increased risk of CD for children born via C-section [38,39], it should be acknowledged that the association between C-section and CD is still controversial [40].”
Backgroundvan der Lugt, B., van Beek, A. A., Aalvink, S., Meijer, B., Sovran, B., Vermeij, W. P., Brandt, R. M. C., de Vos, W. M., Savelkoul, H. F. J., Steegenga, W. T., et al. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0145-z · Cited by 217 · cited 1×
“A balanced gut microbiota also contributes to the maintenance of the mucous layer, especially due to bacteria such as Lactobacillus species and Akkermansia muciniphila [64,65].”
BackgroundWacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., Mäki, M., & Mättö, J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828029a9 · Cited by 207
Lindfors, K., Blomqvist, T., Juuti-Uusitalo, K., Stenman, S., Venäläinen, J., Mäki, M., & Kaukinen, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03635.x · Cited by 204 · cited 2×
“However, few in vitro studies have revealed that microbiota components, specifically Bifidobacteria, can degrade proinflammatory gluten peptides in the small intestine, thus reducing their immunogenic potential [82,99].”
BackgroundPrevalence of Childhood Celiac Disease and Changes in Infant Feeding
Ivarsson, A., Myléus, A., Norström, F., van der Pals, M., Rosén, A., Högberg, L., Danielsson, L., Halvarsson, B., Hammarroth, S., Hernell, O., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1015 · Cited by 198 · cited 1×
“This phenomenon was initially hypothesized to be secondary to the timing of gluten introduction at weaning [10], although two large, randomized, and prospective high-risk, birth cohort-controlled trials have disputed this premise by demonstrating that neither delayed nor early gluten introduction modified the risk of…”
ResultPresence of Bacteria and Innate Immunity of Intestinal Epithelium in Childhood Celiac Disease
Forsberg, G., Fahlgren, A., Horstedt, P., Hammarstrom, S., Hernell, O., & Hammarstrom, M.-L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04157.x · Cited by 187
Nistal, E., Caminero, A., Herrán, A. R., Arias, L., Vivas, S., de Morales, J. M. R., Calleja, S., de Miera, L. E. S., Arroyo, P., & Casqueiro, J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21830 · Cited by 187
Martín, R., Chamignon, C., Mhedbi-Hajri, N., Chain, F., Derrien, M., Escribano-Vázquez, U., Garault, P., Cotillard, A., Pham, H. P., Chervaux, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41738-5 · Cited by 186 · cited 1×
“A balanced gut microbiota also contributes to the maintenance of the mucous layer, especially due to bacteria such as Lactobacillus species and Akkermansia muciniphila [64,65].”
BackgroundKemppainen, K. M., Lynch, K. F., Liu, E., Lönnrot, M., Simell, V., Briese, T., Koletzko, S., Hagopian, W., Rewers, M., She, J.-X., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.033 · Cited by 183 · cited 1×
“Early life infections may be involved in CD onset, and this issue is also supported by cohort studies [52,53].”
ResultAntibiotic exposure and the development of coeliac disease: a nationwide case–control study
Mårild, K., Ye, W., Lebwohl, B., Green, P. H., Blaser, M. J., Card, T., & Ludvigsson, J. F. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-109 · Cited by 175
Sanz, Y., Sánchez, E., Marzotto, M., Calabuig, M., Torriani, S., & Dellaglio, F. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00337.x · Cited by 173
Nistal, E., Caminero, A., Vivas, S., Ruiz de Morales, J. M., Sáenz de Miera, L. E., Rodríguez-Aparicio, L. B., & Casqueiro, J. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.025 · Cited by 172
Duodenal-Mucosal Bacteria Associated with Celiac Disease in Children
Sánchez, E., Donat, E., Ribes-Koninckx, C., Fernández-Murga, M. L., & Sanz, Y. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00869-13 · Cited by 171
Ou, G., Hedberg, M., Hörstedt, P., Baranov, V., Forsberg, G., Drobni, M., Sandström, O., Nyunt Wai, S., Johansson, I., Hammarström, M.-L., et al. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.524 · Cited by 169
D'Argenio, V., Casaburi, G., Precone, V., Pagliuca, C., Colicchio, R., Sarnataro, D., Discepolo, V., Kim, S. M., Russo, I., Del Vecchio Blanco, G., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.95 · Cited by 154 · cited 3×
“In the Neisseriales order, the Neisseriaceae family and the Neisseria genus were significantly more present in active CD patients than in controls [94].”
BackgroundInfluentialLaparra, J. M., Olivares, M., Gallina, O., & Sanz, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030744 · Cited by 153 · cited 1×
“evaluated Bifidobacterium longum CECT 7347 in a murine model of CD, and they found that this specific strain not only diminishes pro-inflammatory cytokine synthesis, such as tumor necrosis factor-alfa (TNF-alfa), but it also reduces jejunal architecture damage [83].”
BackgroundPaneth cells in intestinal physiology and pathophysiology
Gassler, N. (2017) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v8.i4.150 · Cited by 153 · cited 1×
“Paneth cells are key masters of gut homeostasis in innate immunity against noxious pathogens through the release of defensins, lysozyme and phospholipase [86].”
BackgroundDuodenal microbiota composition and mucosal homeostasis in pediatric celiac disease
Cheng, J., Kalliomäki, M., Heilig, H. G., Palva, A., Lähteenoja, H., de Vos, W. M., Salojärvi, J., & Satokari, R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-113 · Cited by 152
Gut microbiota trajectory in early life may predict development of celiac disease
Olivares, M., Walker, A. W., Capilla, A., Benítez‐Páez, A., Palau, F., Parkhill, J., Castillejo, G., & Sanz, Y. (2018) · Microbiome · doi:10.1186/s40168-018-0415-6 · Cited by 152
De Palma, G., Capilla, A., Nova, E., Castillejo, G., Varea, V., Pozo, T., Garrote, J. A., Polanco, I., López, A., Ribes-Koninckx, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030791 · Cited by 150 · cited 1×
“However, the method of infant-feeding influenced the composition of the microbiota, with breast milk favoring Clostridium leptum, Bifidobacterium longum and Bifidobacterium breve gut colonization, therefore slightly switching the fecal microbiome toward the one identified in infants with low HLA-DQ genetic risk [80].”
MethodIntestinal Microbiota Modulates Gluten-Induced Immunopathology in Humanized Mice
Galipeau, H. J., McCarville, J. L., Hübener, S., Litwin, O., Meisel, M., Jabrì, B., Sanz, Y., Murray, J. A., Jordana, M., Alaedini, A., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.07.018 · Cited by 144 · cited 1×
“that gut microbiota can either reduce or exacerbate gliadin-induced damage in a mouse model of CD [95].”
BackgroundInfections and Risk of Celiac Disease in Childhood: A Prospective Nationwide Cohort Study
Mårild, K., Kahrs, C. R., Tapia, G., Stene, L. C., & Størdal, K. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.287 · Cited by 141 · cited 1×
“Early life infections may be involved in CD onset, and this issue is also supported by cohort studies [52,53].”
ResultCeliac Disease — How to Handle a Clinical Chameleon
Fasano, A. (2003) · New England Journal of Medicine · doi:10.1056/nejme030050 · Cited by 138 · cited 1×
“The worldwide prevalence of CD ranges between 1% and 2% in the general population [3,4], with most patients remaining undiagnosed due to the subtle or multiform clinical manifestations of the disease [5].”
BackgroundSelf-citationCaminero, A., McCarville, J. L., Zevallos, V. F., Pigrau, M., Yu, X. B., Jury, J., Galipeau, H. J., Clarizio, A. V., Casqueiro, J., Murray, J. A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.028 · Cited by 136 · cited 2×
“1, Lactobacillus mucosae D5a1 and Lactobacillus rhamnosus LE3) decreased both inflammation and permeability stimulated by ATIs [100].”
BackgroundSánchez, E., De Palma, G., Capilla, A., Nova, E., Pozo, T., Castillejo, G., Varea, V., Marcos, A., Garrote, J. A., Polanco, I., et al. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00365-11 · Cited by 135
Canova, C., Zabeo, V., Pitter, G., Romor, P., Baldovin, T., Zanotti, R., & Simonato, L. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu101 · Cited by 133 · cited 1×
“According to some reports, antibiotic exposure during the first year of life has been associated with an increased risk of developing CD [46,47], however, other studies did not confirm this finding [48–50].”
ResultLaparra, J. M., & Sanz, Y. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22459 · Cited by 131 · cited 1×
“However, few in vitro studies have revealed that microbiota components, specifically Bifidobacteria, can degrade proinflammatory gluten peptides in the small intestine, thus reducing their immunogenic potential [82,99].”
BackgroundFreire, R. H., Ingano, L. A. M., Serena, G., Çetinbaş, M., Anselmo, A. N., Sapone, A., Sadreyev, R. I., Fasano, A., & Senger, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43426-w · Cited by 129 · cited 1×
“Moreover, the same group also showed that butyrate significantly upregulated the expression of genes regulating epithelial integrity in CD organoids [77].”
BackgroundSelf-citationMedina, M., De Palma, G., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2008) · Journal of Inflammation · doi:10.1186/1476-9255-5-19 · Cited by 128
Bodkhe, R., Shetty, S. A., Dhotre, D. P., Verma, A. K., Bhatia, K., Mishra, A., Kaur, G., Pande, P., Bangarusamy, D. K., Santosh, B. P., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00164 · Cited by 128
World Perspective and Celiac Disease Epidemiology
Catassi, C., Gatti, S., & Lionetti, E. (2015) · Digestive Diseases · doi:10.1159/000369518 · Cited by 127 · cited 1×
“Its prevalence, as in many other autoimmune diseases often found in comorbidity with CD [8], has increased over time in geographical regions characterized by a Western lifestyle [9].”
BackgroundIncreased Prevalence of Celiac Disease in School-age Children in Italy
Gatti, S., Lionetti, E., Balanzoni, L., Verma, A. K., Galeazzi, T., Gesuita, R., Scattolo, N., Cinquetti, M., Fasano, A., Catassi, C., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.06.013 · Cited by 120 · cited 1×
“However, the implementation of rotavirus vaccination did not prevent a rise in CD prevalence that has been recently reported in Italian children [58].”
BackgroundSelf-citationDietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
Schilderink, R., Verseijden, C., & de Jonge, W. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00226 · Cited by 115
Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity
Kemppainen, K. M., Vehik, K., Lynch, K. F., Larsson, H. E., Canepa, R. J., Simell, V., Koletzko, S., Liu, E., Simell, O., Toppari, J., et al. (2017) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2017.2905 · Cited by 114
Association Between Antibiotics in the First Year of Life and Celiac Disease
Sander, S. D., Andersen, A. N., Murray, J. A., Karlstad, Ø., Husby, S., & Størdal, K. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.039 · Cited by 112 · cited 1×
“According to some reports, antibiotic exposure during the first year of life has been associated with an increased risk of developing CD [46,47], however, other studies did not confirm this finding [48–50].”
ResultFernandez-Feo, M., Wei, G., Blumenkranz, G., Dewhirst, F. E., Schuppan, D., Oppenheim, F. G., & Helmerhorst, E. J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12249 · Cited by 110
Kalliomäki, M., Satokari, R., Lähteenoja, H., Vähämiko, S., Grönlund, J., Routi, T., & Salminen, S. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318241cfa8 · Cited by 110 · cited 2×
“[71] JPGN 2012 Children (n = 19) Finland Duodenal biopsy qPCR No significant differences in the amounts or frequencies of bacteria were identified between the study groups.”
BackgroundModulation of Type 1 Diabetes Risk by the Intestinal Microbiome
Knip, M., & Honkanen, J. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0933-9 · Cited by 110
Myléus, A., Hernell, O., Gothefors, L., Hammarström, M., Persson, L. Å., Stenlund, H. C., & Ivarsson, A. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-194 · Cited by 107
Discerning the Role of Bacteroides fragilis in Celiac Disease Pathogenesis
Sánchez, E., Laparra, J. M., & Sanz, Y. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00563-12 · Cited by 101
Host–microbiota interactions: epigenomic regulation
Woo, V., & Alenghat, T. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.12.001 · Cited by 99 · cited 1×
“Microbiome-derived SCFA can also modulate host histone deacetylase, therefore epigenetically influencing the function of innate and adaptive immune cells [27].”
BackgroundOlivares, M., Benítez‐Páez, A., Palma, G. D., Capilla, A., Nova, E., Castillejo, G., Varea, V., Marcos, A., Garrote, J. A., Polanco, I., et al. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1451276 · Cited by 98 · cited 3×
“Among infants on formula feeding, on the other hand, a higher number of ETEC was also identified in infants with a high genetic risk versus those of intermediate risk [79].”
BackgroundIncreased Mucosal Expression of Toll‐like Receptor (TLR)2 and TLR4 in Coeliac Disease
Szebeni, B., Veres, G., Dezsőfi, A., Rusai, K., Vannay, Á., Bokodi, G., Vásárhelyi, B., Korponay‐Szabó, I., Tulassay, T., & Arató, A. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318064514a · Cited by 92 · cited 1×
“found higher expressions of TLR2 and TLR4 in untreated and treated CD patients versus controls, as shown both at mRNA and protein levels [70].”
Intestinal T-cell Responses in Celiac Disease – Impact of Celiac Disease Associated Bacteria
Sjöberg, V., Sandström, O., Hedberg, M. E., Hammarström, S., Hernell, O., & Hammarström, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053414 · Cited by 85 · cited 1×
“These species could trigger an IL-17A-driven immune response [91].”
BackgroundWang, C., Zhang, M., Guo, H., Yan, J., Fan, L., Chen, J., Li, Y., & Ren, F. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900262 · Cited by 85
D’Arienzo, R., Stefanile, R., Maurano, F., Mazzarella, G., Ricca, E., Troncone, R., Auricchio, S., & Rossi, M. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02582.x · Cited by 84 · cited 1×
“This suggests that, depending on the strain and on the experimental model, probiotics may have either proinflammatory or immunomodulatory properties [88,89].”
BackgroundValitutti, F., & Fasano, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05646-y · Cited by 84 · cited 1×
“Intestinal permeability is an additional element involved in CD pathogenesis, as a “leaky gut” might initiate the early phases of innate immune activation following the exaggerated trafficking of undigested gluten fragments from the intestinal lumen to the lamina propria [13].”
BackgroundInfluentialSelf-citationPalma, G. D., Capilla, A., Nadal, I., Nova, E., Pozo, T., Varea, V., Polanco, I., Castillejo, G., López, A., Garrote, J. A., et al. (2010) · PubMed · Cited by 83
Sánchez, E., Nadal, I., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-50 · Cited by 83
Papista, C., Gerakopoulos, V., Kourelis, A., Sounidaki, M., Kontana, A., Berthelot, L., Moura, I. C., Monteiro, R. C., & Yiangou, M. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.13 · Cited by 82
Serena, G., Yan, S., Camhi, S. S., Patel, S., Lima, R. S., Sapone, A., Leonard, M. M., Mukherjee, R., Nath, B. J., Lammers, K. M., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12911 · Cited by 81
Self-citationNistal, E., Caminero, A., Herrán, A. R., Pérez-Andres, J., Vivas, S., Ruiz de Morales, J. M., Sáenz de Miera, L. E., & Casqueiro, J. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13111 · Cited by 79
Methods and basic concepts for microbiota assessment
Costa, M., & Weese, J. S. (2019) · The Veterinary Journal · doi:10.1016/j.tvjl.2019.05.005 · Cited by 74 · cited 1×
“In the last decades, one of the major advances in the field of microbiome studies has been the ability to apply culture-independent approaches to determine the microbiome’s composition [18].”
BackgroundLeonard, M. M., Camhi, S. S., Huedo-Medina, T. B., & Fasano, A. (2015) · Nutrients · doi:10.3390/nu7115470 · Cited by 73
Self-citationEmilsson, L., Magnus, M. C., & Størdal, K. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.012 · Cited by 72 · cited 1×
“However, while it is uncertain if these changes might explain some reports of an increased risk of CD for children born via C-section [38,39], it should be acknowledged that the association between C-section and CD is still controversial [40].”
BackgroundPinto-Sánchez, M. I., Smecuol, E., Temprano, M. P., Sugai, E., Gonzalez, A. F., Moreno, M. L., Huang, X., Berčík, P., Cabanne, A. M., Vázquez, H., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000687 · Cited by 72 · cited 1×
“infantis, seems to decrease Paneth cells and expression of alfa-defensin-5 on electronic microscopy of duodenal biopsy when administered in active CD [85].”
BackgroundMcCarville, J. L., Dong, J., Caminero, A., Bermudez-Brito, M., Jury, J., Murray, J. A., Duboux, S., Steinmann, M., Delley, M., Tangyu, M., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.01323-17 · Cited by 71 · cited 1×
“, attenuating gliadin-induced histological damage in NOD/DQ8 mice [84].”
BackgroundModulation of the immune response by probiotic strains in a mouse model of gluten sensitivity
D’Arienzo, R., Maurano, F., Lavermicocca, P., Ricca, E., & Rossi, M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.08.003 · Cited by 66 · cited 1×
“This suggests that, depending on the strain and on the experimental model, probiotics may have either proinflammatory or immunomodulatory properties [88,89].”
Backgroundde Meij, T. G. J., Budding, A. E., Grasman, M. E., Kneepkens, C. M. F., Savelkoul, P. H. M., & Mearin, M. L. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.775666 · Cited by 66
Are ESPGHAN “Biopsy-Sparing” Guidelines for Celiac Disease also Suitable for Asymptomatic Patients?
Trovato, C. M., Montuori, M., Anania, C., Barbato, M., Vestri, A. R., Guida, S., Oliva, S., Mainiero, F., Cucchiara, S., & Valitutti, F. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.285 · Cited by 65 · cited 1×
“Based on more recent epidemiological data, and contrary to the original paradigm, it is now appreciated that CD can present at any age with a broad range of intestinal and extra-intestinal symptoms [6,7].”
BackgroundSelf-citationPalma, G. D., Capilla, A., Nadal, I., Nova, E., Pozo, T., Varea, V., Polanco, I., Castillejo, G., López, A., Garrote, J. A., et al. (2010) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · Cited by 63
Intestinal Staphylococcus spp. and virulent features associated with coeliac disease
Sánchez, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200759 · Cited by 62
Palma, G. D., Kamanová, J., Cinová, J., Olivares, M., Drašarová, H., Tučková, L., & Sanz, Y. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111581 · Cited by 61 · cited 1×
“On the other hand, Bifidobacterium longum CECT 7347 counterbalanced IFN-production as a consequence of gliadin stimulation and increased IL-10 release [97].”
Background(2010) · Current Issues in Molecular Biology · doi:10.21775/cimb.012.001 · Cited by 59 · cited 1×
“It has been noticed that the HLA-DQ genotype can affect early gut microbiota composition [78], and an increased occurrence of pathogenic bacteria such as enterotoxigenic Escherichia coli has also been described in infants genetically at risk for CD [79].”
BackgroundPediatric Celiac Disease: Follow-Up in the Spotlight
Valitutti, F., Trovato, C. M., Montuori, M., & Cucchiara, S. (2017) · Advances in Nutrition · doi:10.3945/an.116.013292 · Cited by 57
Self-citationDuffy, L. C., Raiten, D. J., Hubbard, V. S., & Starke-Reed, P. E. (2015) · Journal of Nutrition · doi:10.3945/jn.114.194936 · Cited by 56
Humoral Immunity Links Candida albicans Infection and Celiac Disease
Corouge, M., Loridant, S., Fradin, C., Salleron, J., Damiens, S., Moragues, M. D., Souplet, V., Jouault, T., Robert, R., Dubucquoi, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121776 · Cited by 50 · cited 1×
“A role for Candida albicans in CD development has been hypothesized based on sequence similarities between a hyphal wall protein and several T-cell gliadin epitopes [59], albeit the only small study on mycobiome next-generation sequencing analysis of duodenal samples showed no difference between adult CD cases and con…”
BackgroundAntibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study
Mårild, K., Ludvigsson, J., Sanz, Y., & Ludvigsson, J. F. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-75 · Cited by 49 · cited 1×
“Some data also suggested that maternal antibiotic assumption during pregnancy shapes the gut microbiota in the offspring [44], albeit a cohort study found no statistically significant association between maternal use of antibiotics during pregnancy and CD risk in the offspring [45].”
BackgroundRintala, A., Riikonen, I., Toivonen, A., Pietilä, S., Munukka, E., Pursiheimo, J.-P., Elo, L. L., Arikoski, P., Luopajärvi, K., Schwab, U., et al. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1444788 · Cited by 49
Metagenomics, culturomics, and the human gut microbiota
Amrane, S., Raoult, D., & Lagier, J. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1467268 · Cited by 49 · cited 1×
“These technologies allow for the identification and quantification of components of the human microbiota by studying nucleic acids (DNA and RNA) from fecal samples or other biological samples [19], which eliminates the need for tissue cultures and also allows the characterization of non-cultivable microbes.”
BackgroundKareva, I. (2019) · Stem Cells · doi:10.1002/stem.3051 · Cited by 48
Wilczyńska, P., Skarżyńska, E., & Lisowska‐Myjak, B. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1387888 · Cited by 42 · cited 1×
“While it is generally assumed that microbiome engraftment occurs at birth during the passage through the vaginal canal, or via maternal skin microbiota in case of cesarean section, there are a few reports showing that a specific microbiota colonizes the placenta [31] and is detectable in the meconium [32], suggesting…”
BackgroundRisk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study
Lebwohl, B., Nobel, Y. R., Green, P. H. R., Blaser, M. J., & Ludvigsson, J. F. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.400 · Cited by 40 · cited 1×
“difficile infection in patients with CD when compared to age- and gender-matched controls [61], albeit study limitations leave open a few areas of uncertainties [62].”
Lähdeaho, M., Lehtinen, M., Rissa, H.-R., Hyöty, H., Reunala, T. L., & Mäki, M. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236457 · Cited by 35 · cited 1×
“Patients with CD display higher antibody titers against human adenovirus serotype 2 [55,56].”
BackgroundLabruna, G., Nanayakkara, M., Pagliuca, C., Nunziato, M., Iaffaldano, L., D’Argenio, V., Colicchio, R., Budelli, A., Nigro, R., Salvatore, P., et al. (2019) · Cellular Microbiology · doi:10.1111/cmi.13035 · Cited by 35
Cataldo, F., Pitarresi, N., Accomando, S., & Greco, L. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.03.021 · Cited by 32 · cited 1×
“The worldwide prevalence of CD ranges between 1% and 2% in the general population [3,4], with most patients remaining undiagnosed due to the subtle or multiform clinical manifestations of the disease [5].”
BackgroundGut microbiota and inflammatory bowel disease: so far so gut!
Holleran, G. E., Lopetuso, L. R., Ianiro, G., Pecere, S., Pizzoferrato, M., Petito, V., Graziani, C., McNamara, D. A., Gasbarrini, A., & Scaldaferri, F. (2017) · Minerva Gastroenterology · doi:10.23736/s1121-421x.17.02386-8 · Cited by 32
Shen, X., Cui, H., & Xu, X. R. (2019) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.18.0973 · Cited by 29 · cited 1×
“antimicrobial molecules into the mucous layer and provide a better defense against pathogens [66].”
BackgroundNguyen, T. T. H., Kim, J. W., Park, J., Hwang, K. H., Jang, T., Kim, C., & Kim, D. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1509.09034 · Cited by 28 · cited 1×
“The human milk oligosaccharides (HMOs) select the growth of commensals such as Bifidobacteria and prevent the growth of potential pathogens such as Clostridium difficile [41,42].”
BackgroundThe gut microbiota: its anatomy and physiology over a lifetime
Gibiino, G., Ianiro, G., Cammarota, G., & Gasbarrini, A. (2017) · Minerva Gastroenterology · doi:10.23736/s1121-421x.17.02405-9 · Cited by 25 · cited 1×
“Consequently, the host and its microbial communities can be viewed as a “superorganism” with mutable immune and metabolic profiles [23].”
BackgroundScaleia, R. L., Barba, M., Nardo, G. D., Bonamico, M., Oliva, S., Nenna, R., Valitutti, F., Mennini, M., Barbato, M., Montuori, M., et al. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.26 · Cited by 22 · cited 1×
“This emphasizes the possibility that the increased IL-17A response seen in active CD could be in part attributable to host-microbiota interactions, and this might also explain why the IL-17A mucosal response in CD is not consistent in some CD patients [92].”
ResultSelf-citationD’Argenio, V., Casaburi, G., Precone, V., Pagliuca, C., Colicchio, R., Sarnataro, D., Discepolo, V., Kim, S. M., Russo, I., Blanco, G. D. V., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.227 · Cited by 22 · cited 1×
“A role for Candida albicans in CD development has been hypothesized based on sequence similarities between a hyphal wall protein and several T-cell gliadin epitopes [59], albeit the only small study on mycobiome next-generation sequencing analysis of duodenal samples showed no difference between adult CD cases and con…”
BackgroundTiberti, C., Montuori, M., Panimolle, F., Trovato, C. M., Anania, C., Valitutti, F., Vestri, A. R., Lenzi, A., Cucchiara, S., & Morano, S. (2016) · Diabetes Care · doi:10.2337/dc16-2095 · Cited by 19
Self-citationGluten-free diet or alternative therapy: a survey on what parents of celiac children want
Norsa, L., Tomba, C., Agostoni, C. V., Branchi, F., Bardella, M. T., Roncoroni, L., Conte, D., & Elli, L. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1064872 · Cited by 18
Kołodziej, M., Patro-Gołąb, B., Gieruszczak‐Białek, D., Skórka, A., Pieścik‐Lech, M., Baron, R., & Szajewska, H. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-317174 · Cited by 17
The microbiome as a possible target to prevent celiac disease
Leonard, M. M., & Fasano, A. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1166954 · Cited by 13
Self-citationIs an enzyme supplement for celiac disease finally on the cards?
König, J., & Brummer, R. J. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1473762 · Cited by 6
C. difficile and celiac disease: the “difficile” to tell association
Valitutti, F., Trovato, C. M., Montuori, M., & Cucchiara, S. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0017-8 · Cited by 2 · cited 1×
“difficile infection in patients with CD when compared to age- and gender-matched controls [61], albeit study limitations leave open a few areas of uncertainties [62].”
Self-citation
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595371 · Cited by 289
Probiotics: Versatile Bioactive Components in Promoting Human Health
Sharifi-Rad, J., Rodrigues, C. F., Stojanović-Radić, Z., Dimitrijević, M., Aleksić, A., Neffe-Skocińska, K., Zielińska, D., Kołożyn-Krajewska, D., Salehi, B., Milton Prabu, S., et al. (2020) · Medicina · doi:10.3390/medicina56090433 · Cited by 190
“For example, the decrease in the number of Firmicutes bacteria and the increase in Proteobacteria have been found in both children and adults with celiac disease [54].”
BackgroundDiet, nutrients and the microbiome
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.04.006 · Cited by 170
Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis
Person, H., & Keefer, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110209 · Cited by 158
“Microbiome research has suggested possible differences in early life gut microbiome composition between infants at genetic risk for CeD who go on to develop this disease and those who do not (Valitutti et al., 2019).”
Background
Metadata
- Authors
- Valitutti, F., Cucchiara, S., & Fasano, A.
- Affiliations
- European Biomedical Research Institute of Salerno (IT)
- Sapienza University of Rome (IT)
- Massachusetts General Hospital (US)
- Corresponding author
- Valitutti, Francesco
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-10-08
- Volume
- 11
- Issue
- 10
- Pages
- 2403
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6835875
- OpenAlex
- W2979828545
- Semantic Scholar
- 1b144444fc982eeb98a666147f80845306896dde
- Cited by
- 157
- References
- 131
- Citations by year
- 2026: 5 · 2025: 23 · 2024: 18 · 2023: 25 · 2022: 30 · 2021: 34 · 2020: 20 · 2019: 2
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- celiac disease, gut microbiota, gut microbiota composition, chronic inflammatory diseases
- MeSH terms
- Gastrointestinal Microbiome, Adult, Bacteria, Bacteroides, Bifidobacterium, Celiac Disease, Child, Cross-Sectional Studies, Diet, Environment, Glutens, Humans, Immunity, Inflammation, Lactobacillus, Milk, Human, Prospective Studies, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.